Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments

Cited by (345)

Items 301–345 of 345

1. Elongation of Fibrils Formed by a Tau Fragment is Inhibited by a Transient Dimeric Intermediate
   Harish Kumar, Jayant B. Udgaonkar · 2022 · The Journal of Physical Chemistry B
2. NDUFA12L mitochondrial complex-I assembly factor: Implications for taupathies
   Mohamed Salama, Wael M.Y. Mohamed · 2015 · Applied & Translational Genomics
3. A streptozotocin-induced model of Alzheimer's disease in mice with wild-type human tau
   Carolyn C. Rudy · 2014
4. Doxycycline interferes with tau amyloid aggregation abolishing its associated neuronal toxicity
   Luciana Medina, Florencia González‐Lizárraga, Antonio Dominguez‐Meijide, Diego Ploper, Valeria Parrales, Sabrina Sequeira, Maria Sol Cima-Omori, Markus Zweckstetter, Elaine Del Bel, Patrick Pierre Michel et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
5. DnaJB1 chaperone inhibits tau aggregation by recognizing its N-terminus
   Paweł M. Wydorski, Paulina Macierzyńska, Sofia Bali, Jaime Vaquer‐Alicea, Łukasz A. Joachimiak · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
6. Implication du canal potassium Kv3.1 dans la lipotoxicité du 7-cétocholestérol, 24S-hydroxycholestérol et de l’acide tétracosanoïque sur des cellules nerveuses 158N et BV-2 : Etude des relations entre Kv3.1, homéostasie potassique et métabolisme peroxysomal dans la maladie d’Alzheimer
   Maryem Bezine · 2017 · theses.fr (ABES)
7. Conformation of Human Microtubule Associated Protein-Tau
   Sadasivam Jeganathan� · 2008 · Max Planck Institute for Plasma Physics
8. Role of P70 S6 kinase in the formation of tau pathologies in Alzheimer´s disease
   Wenlin An · 2005 · Figshare
9. Molecular Mechanisms of Tau Protein Aggregation Inhibition
   Elias Akoury · 2013
10. Pseudophosphorylation of tau modulates its function and induces AD-like changes
    Qian Sun · 2009 · KU ScholarWorks (The University of Kansas)
11. Mouse and stem cell models of frontotemporal dementia
    Miranda E. Orr · 2012 · Montana State University ScholarWorks (Montana State University)
12. Seeded propagation of Tau fibrils
    Paul D. Dinkel · 2013 · Digital Commons - DU (University of Denver)
13. Alternatives Fehlspleißen von Tau Exon 10, Htra2-ß und Clk2 in post mortem Hirngewebe von Alzheimer-Patienten
    H.-J. Möller · 2005
14. Structural Polymorphism in Tau Filaments: An Implication for Neurodegenerative Diseases
    Ayisha Siddiqua · 2012 · Digital Commons - DU (University of Denver)
15. Inhibition of Alzheimer’s type toxic aggregates of tau with fungal secondary metabolites
    Smita R. Paranjape · 2015 · KU ScholarWorks (University of Kansas)
16. Detection and conformational characterization of misfolded proteins in neurodegenerative diseases
    Olga A. Morozova · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
17. Engineering antibody therapeutics and cell culture models for neurodegenerative diseases
    Kyle P. McHugh · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
18. Successful aggregation of Tau protein labelled on its native cysteines
    Martina Radli, Romy E Verdonschot, Luca Ferrari, Stefan Rüdiger · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
19. Development and characterization of cell models of tau aggregation
    Annalisa Cavallini · 2018 · UCL Discovery (University College London)
20. The molecular mechanism of Hsp90-induced oligomerization of Tau
    Sabrina Weickert, Magdalena Wawrzyniuk, Laura John, Stefan Rüdiger, Malte Drescher · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
21. Mechanistic Insight into Tau Fibril Cross-Seeding Barriers: Structural Order and Disorder
    Hilary A. Weismiller · 2019 · Digital Commons - DU (University of Denver)
22. Investigation of the intercellular transmission of α-synuclein, amyloid-β and TDP-43
    Christopher Sackmann · 2019 · Linköping University medical dissertations
23. Polymorphic protein aggregation in tauopathies
    Alexander Sandberg · 2019 · Linköping studies in science and technology. Dissertations
24. Cysteine in Alzheimer's Disease
    Suvarna Pramod Ingale, Rupali Patil, Aman Upaganlawar · 2020 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
25. Investigation on the Physiological and Pathological Aspects of the Proline-Rich Region of the Microtubule-Associated Protein Tau
    Adriana Savastano · 2020
26. Tau and Tauopathies
    Robert Mathew, Guduru Vijay Srinivas, Pavagada Sivasankara Mathuranath · 2010 · Advances in neurobiology
27. Inhibiting disulphide bonding in truncated tau297-391 results in enhanced self-assembly of tau into seed-competent assemblies
    Sebastian Scott Oakley, Karen E. Marshall, Georg Meisl, Alice C. Copsey, Mahmoud Bukar Maina, Robert Milton, Thomas Vorley, John M. D. Storey, Charles R. Harrington, Claude M. Wischik et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
28. Exploring the impact of serine phosphorylation flanking the KxGS motif in the repeat 3 domain of human tau on tubulin detachment
    Selvaa Kumar C, Subha Yegnaswamy, Debjani Dasgupta, Parul Johari, Mahalakshmi Harish · 2025 · Journal of Biomolecular Structure and Dynamics
29. Additional file 1 of Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
    Bryan Frey, David Holzinger, Keenan C. Taylor, Dagmar E. Ehrnhoefer, Andreas Striebinger, Sandra Biesinger, Laura Gasparini, Michael J. O’Neill, Wegner, Florian, Stefan Barghorn et al. · 2024 · Figshare
30. Additional file 1 of Synaptic tau: A pathological or physiological phenomenon?
    Miranda Robbins, Emma L. Clayton, Gabriele S. Kaminski Schierle · 2021 · Figshare
31. Étude de l’agrégation des protéines intrinsèquement désordonnées impliquées dans les maladies d’Alzheimer et de Parkinson
    Juan M. Lopez · 2015 · theses.fr (ABES)
32. Coupling Laser with Mass Spectrometry for Biomolecules Characterization : From Peptides towards Protein Fibrils
    Mohammad A. Halim · 2017
33. Déterminants structuraux d’agrégats de Tau distincts : vers de nouveaux outils moléculaires pour discriminer les tauopathies
    Emilie Caroux · 2019 · theses.fr (ABES)
34. La protéine prion cellulaire : rôles physiologiques et implications croisées dans les maladies neurodégénératives amyloïdes
    Vincent Baudouin · 2020 · theses.fr (ABES)
35. Caractérisation d'un nouveau mode de fixation de la protéine Tau aux microtubules
    Liza Ammar Khodja · 2022 · theses.fr (ABES)
36. Liaison et impact du zinc sur deux protéines associées aux maladies neuro-dégénératives : tau et TDP-43
    Dahbia Yatoui · 2022 · theses.fr (ABES)
37. Development of Aryl Cyano Amides for Fluorescence Discrimination of Tau and Amyloid Beta Deposits in Tissue
    R. Erin Jessup, Rachel S. Ehrlich, Kristine L. Teppang, Saswata Dasgupta, Christina J. Sigurdson, Jerry Yang · 2026 · ACS Chemical Neuroscience
38. Contribution of G4 Structure to Alzheimer’s Disease and Tau Pathology
    Lena M. Kallweit · 2026
39. Attenuation of Tau-Mediated β-Amyloid1-42 Aggregation by Native PLGA Nanoparticles and Its Relevance to Alzheimer Disease Pathology
    Pallabi Sil Paul, Aliza Borenstein-Katz, Klinton Shmeit, Holger Wille, Satyabrata Kar · 2026 · International Journal of Molecular Sciences
40. BindingDB Entry 50042999: Progress and developments in tau aggregation inhibitors for Alzheimer disease.
    BindingDB · 2014 · UC San Diego
41. BindingDB Entry 50002303: Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    BindingDB · 2020 · UC San Diego
42. BindingDB Entry 50012860: The multifunctional dopamine D
    BindingDB · 2022 · UC San Diego
43. BindingDB Entry 7750: Structural determinants of Tau aggregation inhibitor potency.
    BindingDB · 2017 · UC San Diego
44. Modifications of the tau protein and their varied effects on aggregation and function
    Benjamin Combs · 2013 · KU ScholarWorks (The University of Kansas)
45. Solid-state NMR characterization of Alzheimer-like tau amyloid fibrils
    Venita Daebel · 2012